?1 prior program of chemotherapy for Highly developed breast most cancers and over the total trial, earlier exposure to any FGFR inhibitor, main surgical procedure or radiotherapy in four months previous to first dose of study remedy and using potent inhibitors or inducers of CYP3A4 or CYP2D6. Any of the next cardiac conditions precluded people mov